Transport of radiopharmaceuticals

Key takeaways
Plan backward from the clinical use window and the activity required at the reference time.
Radioactive classification, drug quality requirements and receiving authorization are separate controls.
Packaging must address the actual radiation, containment and product-condition requirements together.
Air acceptance and a qualified receiving process must be confirmed before dispatch.
The transport of radiopharmaceuticals must deliver the right product with the required activity and quality within a usable clinical window. Radioactive decay continues during preparation, staging and transit, so the route has to be planned around more than a delivery date.
Radiopharmaceutical logistics brings together radioactive-material transport rules, pharmaceutical handling requirements and the receiving facility's authorization. Cooling cannot stop radioactive decay, and rapid transport cannot compensate for an unacceptable package or an unauthorized recipient.
Start with the required activity and clinical window
Radiopharma transportation should be planned backward from the agreed reference time and receiving workflow. The supplier and clinical team establish the product's activity, calibration or reference time, expiry and use instructions. Logistics personnel use those requirements to build a feasible movement without making clinical dosing decisions.
As a simple decay illustration, a radionuclide has half its initial activity after one physical half-life, ignoring other changes. The operational impact of a two-hour delay therefore depends strongly on the radionuclide. Product expiry, chemical stability and preparation requirements can impose additional limits.
Include manufacturing release, airport processing, road transit, customs where relevant and receiving checks in the schedule. A booked flight time is only one part of nuclear medicine logistics.
Confirm classification and authorization before routing
The trained shipper must establish the applicable radioactive transport entry, package requirements and hazard communication from the material's form, activity and other relevant properties. Some shipments qualify for exceptions, while others require more extensive packaging and documents.
Mercury's radioactive material classification guide covers the category and label distinctions. The regulatory framework is set out in 49 CFR Part 173, Subpart I. Do not assume that every radiopharmaceutical has the same declaration or radioactive-label requirement.
Separately verify the sender and receiver's relevant authorizations, including NRC or Agreement State requirements where applicable. A carrier's willingness to move the package does not establish the recipient's authority to possess or use its contents.
Packaging must protect the radioactive and pharmaceutical contents
Handling of radiopharmaceuticals begins with the actual product specification. Temperature conditions vary by formulation. Some products require refrigeration, while others have different supported conditions. Apply the manufacturer's instructions and quality requirements rather than a universal 2–8°C rule.
The following controls must work as one shipment configuration.
Control | Purpose | What to verify |
|---|---|---|
Containment | Prevent loss of radioactive contents | Package suitability, permitted contents and closure instructions |
Shielding | Control radiation exposure | Design, placement and required radiation measurements |
Thermal protection where needed | Maintain the product's supported conditions | Qualified packout with the actual shielding and payload configuration |
Physical protection | Protect containers and prevent movement | Assembly, restraint and handling suitability |
Identification and records | Support safe transport and receipt | Correct marks, labels, activity information and applicable documents |
A heavy shield can affect the packout's thermal behavior. Assess the complete configuration rather than combining separately tested components without review. For thermal-system choices, see Mercury's active and passive cold chain comparison.
Shipping radiopharmaceuticals by air
Air transport is possible for eligible shipments, subject to the actual entry, package type, activity, transport index, national requirements and operator acceptance. The color of a radioactive label alone does not determine whether a shipment must use a cargo-only aircraft.
US aircraft restrictions are addressed in 49 CFR 175.700. Airlines can apply narrower acceptance policies. Confirm the complete route and every relevant operator before committing to a clinical delivery time.
Radiopharma logistics should include a tested recovery plan for missed acceptance, flight cancellation or delayed cargo release. An alternative flight is useful only if the package remains eligible, sufficient usable time remains and the destination can still receive it.
Arrange the radioactive delivery handoff in advance
Radiopharmaceuticals delivery needs a receiving arrangement that fits the facility's license, procedures and clinical operation. Identify the approved delivery point, responsible receiving personnel, after-hours access and escalation contact before departure.
10 CFR 20.1906 sets out NRC licensee requirements for receiving and opening packages, including applicable monitoring and notification duties. It should not be paraphrased as a universal rule that every package must be handed directly to a nuclear pharmacist. The facility's approved process and the particular regulatory conditions control.
A delivery scan does not establish clinical release. The receiving organization must perform its required package, condition and product checks before use.
Choose a provider for the actual radioactive logistics task
Assess operational evidence rather than a general claim of dangerous goods expertise:
Experience and trained personnel for the relevant radioactive-material movements.
Confirmed carrier acceptance and realistic route milestones.
Coordination with the manufacturer and authorized receiving facility.
Suitable packaging, condition records and controlled handoffs.
Out-of-hours escalation and approved recovery options.
Mercury's time-sensitive shipping guide explains deadline-led coordination. For radiopharmaceuticals, that coordination must remain tied to the product's decay and quality limits, the package authorization and the receiving facility's requirements throughout the movement.



